Filter results
You can narrow down the results using the filters
Audience
Publication type
Topics
Our work
Diseases
9584 results
-
Darling Downs and West Moreton (Qld) Primary Health Network (PHN) map – Modified Monash Model (MMM) remoteness area
This map shows the Modified Monash Model remoteness area classifications of the Darling Downs and West Moreton (Qld) Primary Health Network. -
Darling Downs and West Moreton (Qld) Primary Health Network (PHN) map – socioeconomic disadvantage
This map shows the most socioeconomically disadvantaged areas within the Darling Downs and West Moreton (Qld) Primary Health Network. -
Darling Downs and West Moreton (Qld) Primary Health Network (PHN) map – topographic
This map shows the geographical area of the Darling Downs and West Moreton (Qld) Primary Health Network. -
Gold Coast (Qld) Primary Health Network (PHN) map – Modified Monash Model (MMM) remoteness area
This map shows the Modified Monash Model remoteness area classifications of the Gold Coast (Qld) Primary Health Network. -
Gold Coast (Qld) Primary Health Network (PHN) map – socioeconomic disadvantage
This map shows the most socioeconomically disadvantaged areas within the Gold Coast (Qld) Primary Health Network. -
Gold Coast (Qld) Primary Health Network (PHN) map – topographic
This map shows the geographical area of the Gold Coast (Qld) Primary Health Network. -
Northern Queensland Primary Health Network (PHN) map – Modified Monash Model (MMM) remoteness area
This map shows the Modified Monash Model remoteness area classifications of the Northern Queensland Primary Health Network. -
Northern Queensland Primary Health Network (PHN) map – socioeconomic disadvantage
This map shows the most socioeconomically disadvantaged areas within the Northern Queensland Primary Health Network. -
Northern Queensland Primary Health Network (PHN) map – topographic
This map shows the geographical area of the Northern Queensland Primary Health Network. -
Western Queensland Primary Health Network (PHN) map – Modified Monash Model (MMM) remoteness area
This map shows the Modified Monash Model remoteness area classifications of the Western Queensland Primary Health Network. -
Western Queensland Primary Health Network (PHN) map – socioeconomic disadvantage
This map shows the most socioeconomically disadvantaged areas within the Western Queensland Primary Health Network. -
Western Queensland Primary Health Network (PHN) map – topographic
This map shows the geographical area of the Western Queensland Primary Health Network. -
24/7 registered nurses in aged care homes
This fact sheet helps older people, their families and carers understand the 24/7 registered nurse requirement for approved residential aged care. -
Care minutes in aged care homes
This fact sheet helps older people, their families and carers understand the care minutes requirement for residential aged care. -
Life Saving Drugs Program – Acid sphingomyelinase deficiency (ASMD) types A/B and B – Reapplication
Treating physicians use this form to reapply each year for a patient to receive ongoing LSDP medication for ASMD types A/B and B. -
Life Saving Drugs Program – Acid sphingomyelinase deficiency (ASMD) types A/B and B – Patient test results spreadsheet
Specialists use this spreadsheet to report their patient's test results when reapplying for treatment under the Life Saving Drugs Program. -
Thriving Kids Advisory Group communique – September 2025
This communique is published following each meeting of the Thriving Kids Advisory Group. It summarises the meeting discussions and outcomes. -
Support at Home – Frequently asked questions for older people
This document answers some frequently asked questions from older people, families and carers about the Support at Home program following the webinar on 14 August 2025. -
Life Saving Drugs Program – Acid sphingomyelinase deficiency (ASMD) types A/B and B – Guidelines
These guidelines contain the general, initial and ongoing eligibility requirements to access treatment for acid sphingomyelinase deficiency (ASMD) types A/B and B under the Life Saving Drugs Program. -
Life Saving Drugs Program – Acid sphingomyelinase deficiency (ASMD) types A/B and B – Initial application
Treating physicians use this application form to apply for a patient to access LSDP medication for ASMD types A/B and B for the first time, or after a break. -
Letter to older people about the Support at Home program – full pensioner approved before 12 September 2024
A copy of the letter sent to older people who are full pensioners and approved for a Home Care Package before 12 September 2024. The letter provides more information about the estimated financial contribution to aged care. -
Letter to older people about the Support at Home program – full pensioner approved after 12 September 2024
A copy of the letter sent to older people who are full pensioners and approved for a Home Care Package after 12 September 2024. The letter provides more information about the estimated financial contribution to aged care. -
Letter to older people about the Support at Home program – part-pensioner approved before 12 September 2024
A copy of the letter sent to older people who are part-pensioners and approved for a Home Care Package before 12 September 2024. The letter provides more information about the estimated financial contribution to aged care. -
Letter to older people about the Support at Home program – approved after 12 September 2024 or financial information not disclosed
A copy of the letter sent to older people who were approved for a Home Care Package after 12 September 2024 or have not disclosed financial information. The letter provides more information about the estimated financial contribution to aged care. -
Unassessed CHSP clients with exceptional circumstances
This fact sheet includes information on how Commonwealth Home Support Programme (CHSP) providers can help their current unassisted clients apply for consideration under the exceptional circumstances pathway, if they cannot be assessed due to their circumstances.